ArticleProceedings of the National Academy of Sciences of the United States of America2024
The
Abstract read
In one paragraph
Article in Proceedings of the National Academy of Sciences of the United States of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- SORL1 variant links endosomal amyloid precursor protein mis-sorting to axonal transport defects and neuronal dysfunction.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026Article
- SORLA up-regulation suppresses pathological effects in aged tauopathy mouse brain.Science advances · 2026Article
- Alzheimer's disease risk single nucleotide polymorphism rs11218343 is linked to functional expression of SORL1 in microglia.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026Article
- Estradiol ameliorates AD pathology and cognitive deficits by SORLA-mediated APP endosomal trafficking.Alzheimer's research & therapy · 2026Article
- Domain mapping of disease mutations reveals pathogenic SORL1 variants in Alzheimer's disease.Molecular neurodegeneration · 2025Article
- Development of Cellular Energy Metabolism During Differentiation of Human iPSCs into Cortical Neurons.Molecular neurobiology · 2025Article
- Genetic testing of common and rare variants in dementia patients from a memory clinic : Dementia-related genetic testing in memory clinic.Alzheimer's research & therapy · 2025Article
- Familial Alzheimer's disease mutation identifies novel role of SORLA in release of neurotrophic exosomes.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025Article
- Amyloid-Related Imaging Abnormality (ARIA) Beyond the APOE-ε4 Allele.Chronic diseases and translational medicine · 2025Review
- Plasma and CSF Amyloid-β42 Predict Plasma Sortilin, Which Influences Cognitive Impairment via Mediation of Whole-Brain Volume: A 12-Month Longitudinal Study Across the Alzheimer's Disease Spectrum.Journal of molecular neuroscience : MN · 2025Article
- The impact of rare genetic variants on Alzheimer disease.Nature reviews. Neurology · 2025Review
- Lipidome disruption in Alzheimer's disease brain: detection, pathological mechanisms, and therapeutic implications.Molecular neurodegeneration · 2025Review
- Functional characterization ofPhilosophical transactions of the Royal Society of London. Series B, Biological sciences · 2024Article
- A familial missense variant in the Alzheimer's disease gene SORL1 impairs its maturation and endosomal sorting.Acta neuropathologica · 2024Article
- Pharmacologic enhancement of retromer rescues endosomal pathology induced by defects in the Alzheimer's gene SORL1.Stem cell reports · 2023Article
- A familial missense variant in the Alzheimer's Disease genebioRxiv : the preprint server for biology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Anne Mette G JensenDepartment of Biomedicine, Aarhus University, Aarhus C DK8000, Denmark.
Jan RaskaDepartment of Histology and Embryology, Faculty of Medicine, Brno 62500, Czech Republic.
Petr FojtikDepartment of Biomedicine, Aarhus University, Aarhus C DK8000, Denmark.
Giulia MontiDepartment of Biomedicine, Aarhus University, Aarhus C DK8000, Denmark.
Melanie LundingDepartment of Biomedicine, Aarhus University, Aarhus C DK8000, Denmark.
Simona BartovaDepartment of Histology and Embryology, Faculty of Medicine, Brno 62500, Czech Republic.
Veronika PospisilovaDepartment of Histology and Embryology, Faculty of Medicine, Brno 62500, Czech Republic.ORCID 0000-0003-2559-2252
Sven J van der LeeAlzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam University Medical Center 1081 HV, Amsterdam, The Netherlands.
Jasper Van DongenComplex Genetics of Alzheimer's Disease Group, Vlaams Instituut voor Biotechnologie (VIB) Center for Molecular Neurology, VIB 2000, Antwerp, Belgium.
Liene BossaertsDepartment of Biomedical Sciences, University of Antwerp 2000, Antwerp, Belgium.
Christine Van BroeckhovenDepartment of Biomedical Sciences, University of Antwerp 2000, Antwerp, Belgium.ORCID 0000-0003-0183-7665
Oriol Dols-IcardoInstitut d'Investigacions Biomèdiques Sant Pau-Hospital de Sant Pau, Universitat Autònoma de Barcelona 08041, Barcelona, Spain.
Alberto LléoCentro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas, CIBERNED 28029, Madrid, Spain.
Sonia BelliniMolecular Markers Laboratory, Instituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Centro San Giovanni di Dio Fatebenefratelli 25125, Brescia, Italy.ORCID 0000-0002-6162-252X
Roberta GhidoniMolecular Markers Laboratory, Instituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Centro San Giovanni di Dio Fatebenefratelli 25125, Brescia, Italy.ORCID 0000-0002-7691-1957
Marc HulsmanAlzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam University Medical Center 1081 HV, Amsterdam, The Netherlands.
Gregory A PetskoAnn Romney Center for Neurologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA 02115.ORCID 0000-0003-3668-3694
Kristel SleegersComplex Genetics of Alzheimer's Disease Group, Vlaams Instituut voor Biotechnologie (VIB) Center for Molecular Neurology, VIB 2000, Antwerp, Belgium.
Dasa BohaciakovaDepartment of Histology and Embryology, Faculty of Medicine, Brno 62500, Czech Republic.
Henne HolstegeAlzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam University Medical Center 1081 HV, Amsterdam, The Netherlands.
Olav M AndersenDepartment of Biomedicine, Aarhus University, Aarhus C DK8000, Denmark.ORCID 0000-0003-4226-3354
Funding
Alzheimer's Association (AA) ADSF-21-831378-CAlzheimer's Association (AA) T-PEP-23-969313Czech Research Council NU22J-08-00075Health-Holland LSHM20106Independent Research Fund Denmark 3101-00065BMEYS LX22NPO5107Novo Nordisk Fonden (NNF) NNF20OC0064162Rainwater Charitable Foundation (RCF) T-PEP-23-969313ZonMw (Netherlands Organisation for Health Research and Development) 733050512ZonMw (Netherlands Organisation for Health Research and Development) 73305095007
Abstract
Truncating genetic variants of
Indexed as
Alzheimer DiseaseEndosomesLDL-Receptor Related ProteinsMembrane Transport ProteinsPedigreeAgedFemaleHEK293 CellsHumansMaleMiddle AgedMutation, MissenseProtein MultimerizationProtein TransportLDL-Receptor Related ProteinsMembrane Transport ProteinsSORL1 protein, human3Fn-domaindimerizationretromerSORL1-associated Alzheimer’s diseaseSORLA
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.